🔗 Visit the ClinicalTrials.gov page for NCT02020889
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. | N Engl J Med | 2017 | 4.55 |
| 2 | Eosinophils in vasculitis: characteristics and roles in pathogenesis. | Nat Rev Rheumatol | 2014 | 1.24 |
| 3 | Eosinophils in mucosal immune responses. | Mucosal Immunol | 2015 | 0.97 |
| 4 | State of the art in the treatment of systemic vasculitides. | Front Immunol | 2014 | 0.90 |
| 5 | Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. | Curr Opin Allergy Clin Immunol | 2016 | 0.84 |
| 6 | Updates in ANCA-associated vasculitis. | Eur J Rheumatol | 2016 | 0.75 |